Diabetic metabolic disorder including DM leads to β-amyloid protein (Aβ) generation and activation of NF-κB signaling pathway in the hippocampus, making it possible to attenuate DM complicated with CI by inhibiting NF-κB pathway [14]. The gene discussed is NFKB1; the disease is diabetes mellitus.